JP Patent

JP7054721B2 — Ｂｔｋ阻害剤としての４－イミダゾピリダジン－１－イル－ベンズアミドおよび４－イミダゾトリアジン－１－イル－ベンズアミド

Assigned to メルク・シャープ・エンド・ドーム・ベー・フェー · Expires 2022-04-14 · 4y expired

What this patent protects

Patent listed against Calquence.

Drugs covered by this patent

Patent Metadata

Patent number
JP7054721B2
Jurisdiction
JP
Classification
—
Expires
2022-04-14
Drug substance claim
No
Drug product claim
No
Assignee
メルク・シャープ・エンド・ドーム・ベー・フェー
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.